Sign up USA
Proactive Investors - Run By Investors For Investors

Daily CryptoCann™ Report: Walmart files a patent for blockchain delivery system; Michigan approves new conditions for its medicinal marijuana program

The patent application describes a blockchain-based system of lockers for package pick-up
Daily CryptoCann™ Report: Walmart files a patent for blockchain delivery system; Michigan approves new conditions for its medicinal marijuana program
Michigan has approved new conditions for its medical marijuana program, including arthritis and autism

The Crypto Report

Walmart Inc (NYSE:WMT) has filed a patent for a blockchain-based delivery management system, according to a Coin Telegraph report.

The patent application details a blockchain-based system of lockers that will reserve a delivered item until the buyer can pick it up. The blockchain system would determine which lockers are occupied and which are free to use.

The retail giant is no stranger to blockchain, previously filing patents to apply the technology to medical wearables, energy consumption, food and package tracking.

READ: Daily CryptoCann™ Report: Google co-founder Sergey Brin admits he missed the boat on blockchain; 'Marijuanapocalypse' hits California cannabis industry

Up north, Canadian crypto exchange Coinsquare launched Coinsquare Licensing, a division of the exchange that will offer digital currency solutions to domestic and international businesses.

"The demand for a product like this is a testament to the growing appetite for digital currency integration both in Canada and abroad,” said CEO Cole Diamond in a statement.

The Toronto-based trading platform also announced a partnership with blockchain investment bank DLTa 21 to launch a digital currency trading platform in Japan.

The trading platform will be created using Coinsquare’s technology.

The Cann Report

Canntab Therapeutics Ltd (CSE:PILL) has announced a profit-sharing collaboration with medicinal marijuana producer FSD Pharma Inc.

FSD will help the Canadian company obtain a license to produce and sell cannabis under the country’s new legislation.

As per the deal, Canntab will give FSD half of the profits it receives on any retail sales of Canntab products through FSD Pharma’s channels. FSD can also retain half of the profits on its sales of Canntab products.

Canntab will also receive 10,000 square feet of space at FSD’s Ontario facility to build its own manufacturing facility.

READ: Canntab Therapeutics unveils collaboration with FSD Pharma ahead of Canada's nationwide legalization

In other medicinal cannabis news, Michigan has approved new conditions for its medical marijuana program, per a High Times report.

The health conditions that qualify now include arthritis, autism, obsessive-compulsive disorder and Parkinson’s disease.

Conditions that were left off the list include anxiety, asthma, diabetes and depression.

The change is effective immediately.

 

Contact Lenore Fedow at [email protected]

Follow her on Twitter@LenoreMariee

Join our Crypto, Blockchain and Cannabis Telegram group here
View full WMT profile View Profile

Walmart Inc Timeline

Related Articles

H&T Pawnbrokers store
July 02 2018
Last year the company saw gross profits jump 45% thanks to a booming personal loan book and robust sales of luxury second-hand watches and jewellery.
Flying Brands
July 17 2018
“We look forward to the future with confidence and excitement," said Flying Brands boss Trevor Brown.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use